SpyBiotech receives more than $4 million to develop vaccine platform
UK-based SpyBiotech has received a grant of more than $4 million from the Bill &…
The Covid-19 pandemic began as a few scattered cases in China, but within months, the respiratory infection had swept the world. The years 2020 and 2021 turned into a rollercoaster ride for the world’s population, with millions of people dead, livelihoods destroyed, and movement between countries plummeting.
Despite the strained situation, academic researchers and biotech and pharma companies globally have come together to develop protective vaccines and treatments against Covid-19. While we still have a long road ahead before this pandemic is declared over, the life sciences industry is bringing us closer to this moment with every new discovery, trial result, and fundraise. Read on to learn about the latest research, investments, trends, and pipeline developments.
European Biotech Industry Report 2021: A Year of European Biotechnology
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations in the biotech and pharma industry.
Go to ReportUK-based SpyBiotech has received a grant of more than $4 million from the Bill &…
ExeVir Bio, and its scientific founders at Belgium’s VIB, Flanders’ leading life sciences institute, have…
Scancell Holdings plc, which develops novel immunotherapies for the treatment of cancer and infectious disease,…
The Foundation for the National Institutes of Health (FNIH) takes on cancer through public-private research…
pHion Therapeutics is a U.K.-based vaccine development company. It is developing a pipeline of therapeutic…
By Claudia Tripp and Katie Nelson, Kadans Science Partner Collaboration has underpinned some of the…
Ascletis Pharma Inc. has announced the dosing of four healthy subjects in its multiple-dose escalation…
Phesi, a global provider of patient-centric data analytics, has released the results of its global…
ExeVir Bio, a Belgian biotech company developing nanobody therapies for broad protection against infectious diseases,…
Ethris GmbH is to collaborate with U.K.-based DIOSynVax to jointly develop a protective mRNA vaccine…
Atriva Therapeutics’ mission is to develop an antiviral therapy platform against severe respiratory and systemic…
Nykode Therapeutics ASA has entered into a strategic manufacturing partnership with Richter-Helm BioLogics GmbH &…